Top Markets
Coin of the day
GSK plc GSK plc

GSK plc

GSK
Classificação em ações #9382
GSK plc is a global pharmaceutical and healthcare company, deeply involved in... GSK plc is a global pharmaceutical and healthcare company, deeply involved in the research, development, production, and commercialization of a diverse range of medicinal and wellness products. Its operations span the United Kingdom, the United States, and numerous other international markets. The company structures its operations across four primary divisions: Pharmaceuticals, Pharmaceutical R&D, Vaccines, and Consumer Healthcare. Within its Pharmaceuticals segment, GSK provides treatments addressing a wide array of therapeutic areas. These include respiratory conditions, HIV, immuno-inflammatory diseases, oncology, viral infections, central nervous system disorders, cardiovascular and urogenital health, metabolic imbalances, bacterial infections, and dermatological issues. The Consumer Healthcare division offers products across categories such as wellness, oral hygiene, nutritional supplements, and skin health. These consumer offerings come in a variety of formats, including oral dosage forms (e.g., tablets, syrups, lozenges, gummies, soft chews, effervescents), topical applications (e.g., gels, creams, patches, lip balms), nasal sprays, and a comprehensive range of oral hygiene products (e.g., toothpastes, mouthwashes, denture care items), alongside other specialized formulations like infant drops and wipes. GSK actively engages in various collaborative ventures. Its collaboration agreements include partnerships with 23andMe, Lyell Immunopharma, Inc., Novartis, Sanofi SA, Surface Oncology, Progentec Diagnostics, Inc., Alector, Inc., and CureVac AG. Additionally, the company maintains strategic alliances with IDEAYA Biosciences, Inc. and Vir Biotechnology, Inc. Originally established in 1715, the company operated under the name GlaxoSmithKline plc until its rebranding to GSK plc in May 2022. Its corporate headquarters are situated in Brentford, United Kingdom.
Preço da ação
$25.28
Última sincronização: 2026-09-18
Valor de mercado
$1.01B
Variação (1 dia)
-2.29%
Variação (1 ano)
-37.84%
País
GB
Negociar GSK plc (GSK)

Categoria

Receita da GSK plc (GSK)
Receita em Jun 2026 TTM: $45.18B
De acordo com os últimos relatórios financeiros da GSK plc, a receita atual da empresa (TTM) é $45.18B. Em 2024, a empresa obteve uma receita de $39.37B um aumento em relação a a receita do ano 2023, que foi de $38.61B. A receita é o valor total gerado pela venda de bens ou serviços. Ao contrário do lucro, nenhuma despesa é subtraída.
Histórico de receita da GSK plc de 2000 a 2026
Receita no final de cada ano
Ano Receita Alterar
2026 (TTM) $45.18B 5.15%
2025 $42.97B 9.13%
2024 $39.37B 1.98%
2023 $38.61B 8.83%
2022 $35.48B 6.25%
2021 $33.39B 0.28%
2020 $33.30B -25.61%
2019 $44.76B 14.02%
2018 $39.26B -3.77%
2017 $40.79B 18.52%
2016 $34.42B -2.36%
2015 $35.25B -1.64%
2014 $35.84B -18.35%
2013 $43.90B 2.38%
2012 $42.87B 0.88%
2011 $42.50B -3.83%
2010 $44.19B -3.75%
2009 $45.91B 29.14%
2008 $35.55B -21.53%
2007 $45.31B -0.48%
2006 $45.53B 22.17%
2005 $37.27B -2.94%
2004 $38.40B 0.32%
2003 $38.27B 12.00%
2002 $34.17B 14.47%
2001 $29.85B 10.60%
2000 $26.99B 0.00%
Receita de empresas similares ou concorrentes
Empresa Receita Diferença de Receita País
$79.67B 76.33%
US
$97.93B 116.76%
US
$64.39B 42.51%
US
$77.52B 71.58%
CH
$66.40B 46.97%
US